Equities research analysts at Cantor Fitzgerald initiated coverage on shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) in a research report issued to clients and investors on Monday, ...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the ...

Piper Sandler analyst David Amsellem reiterated a Hold rating on Biogen (BIIB – Research Report) today and set a price target of $138.00. The ...

SUPN insiders have traded $SUPN stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales. Here’s a ...

After hours: January 22 at 4:35:29 PM EST Loading Chart for SUPN ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Pre-Market: 4:19:47 a.m. EST ...

Biscayne was sold to Supernus Pharmaceuticals in October of 2018 for future development. Before heading the two Biscayne companies, Dr. Collins held several top leadership positions at companies ...

Newron Pharmaceuticals, Supernus Pharmaceutical, Britannia Pharmaceuticals, Pharma Two B, among others. Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth ...